Healthcare stocks were mixed Thursday afternoon, with the NYSE Healthcare Index fractionally lower and the State Street Health Care Select Sector SPDR ETF (XLV) up 0.1%.
The iShares Biotechnology ETF (IBB) decreased 0.3%.
In corporate news, Novartis (NVS) defeated a bid by Accord Healthcare to invalidate its Entresto patent, with a UK court ruling that the patent and a related protection certificate remain valid, Reuters reported. The court also ruled that Accord's planned generic version of Entresto would infringe Novartis' patent, the report said. Novartis shares were fractionally higher.